The transCampus Metabolic Training Programme Explores the Link of SARS-CoV-2 Virus to Metabolic Disease.

Mar 4, 2021

Contributor: S R Bornstein,K Guan,C Brunßen,G Mueller,V Kamvissi-Lorenz,R Lechler,R Trembath,M Mayr,L Poston,R Sancho, ,S Ahmed,E Alfar,B Aljani,T C Alves,S Amiel,C L Andoniadou,M Bandral,A Belavgeni,I Berger,A Birkenfeld,E Bonifacio,T Chavakis,P Chawla,P Choudhary,A M Cujba,L F Delgadillo Silva,T Demcollari,D M Drotar,S Duin,N N El-Agroudy,A El-Armouche,A Eugster,M Gado,A Gavalas,M Gelinsky,M Guirgus,S Hansen,E Hanton,M Hasse,H Henneicke,C Heller,H Hempel,C Hogstrand,D Hopkins,L Jarc,P M Jones,M Kamel,S Kämmerer,A J F King,A Kurzbach,C Lambert,Y Latunde-Dada,I Lieberam,J Liers,J W Li,A Linkermann,S Locke,B Ludwig,T Manea,F Maremonti,Z Marinicova,B M McGowan,M Mickunas,G Mingrone,K Mohanraj,H Morawietz,N Ninov,M Peakman,S J Persaud,J Pietzsch,E Cachorro,T J Pullen,I Pyrina,F Rubino,A Santambrogio,F Schepp,P Schlinkert,L D Scriba,R Siow,M Solimena,F M Spagnoli,S Speier,A Stavridou,C Steenblock,A Strano,P Taylor,A Tiepner,W Tonnus,T Tree,F Watt,M Werdermann,M Wilson,N Yusuf,C G Ziegler

Currently, we are experiencing a true pandemic of a communicable disease by the virus SARS-CoV-2 holding the whole world firmly in its grasp. Amazingly and unfortunately, this virus uses a metabolic and endocrine pathway via ACE2 to enter our cells causing damage and disease. Our international research training programme funded by the German Research Foundation has a clear mission to train the best students wherever they may come from to learn to tackle the enormous challenges of diabetes and its complications for our society. A modern training programme in diabetes and metabolism does not only involve a thorough understanding of classical physiology, biology and clinical diabetology but has to bring together an interdisciplinary team. With the arrival of the coronavirus pandemic, this prestigious and unique metabolic training programme is facing new challenges but also new opportunities. The consortium of the training programme has recognized early on the need for a guidance and for practical recommendations to cope with the COVID-19 pandemic for the community of patients with metabolic disease, obesity and diabetes. This involves the optimal management from surgical obesity programmes to medications and insulin replacement. We also established a global registry analyzing the dimension and role of metabolic disease including new onset diabetes potentially triggered by the virus. We have involved experts of infectious disease and virology to our faculty with this metabolic training programme to offer the full breadth and scope of expertise needed to meet these scientific challenges. We have all learned that this pandemic does not respect or heed any national borders and that we have to work together as a global community. We believe that this transCampus metabolic training programme provides a prime example how an international team of established experts in the field of metabolism can work together with students from all over the world to address a new pandemic.
Thieme. All rights reserved.

Author

admin

View all posts

About The Expert

S R Bornstein

Department of Medicine III, Medical Faculty Carl Gustav Carus, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Germany.

Division of Diabetes & Nutritional Sciences, Faculty of Life Sciences & Medicine, King’s College London, London, UK.

University Hospital Zurich, Department of Endocrinology and Diabetology, Zurich, Switzerland.

Paul Langerhans Institute Dresden (PLID) of the Helmholtz Center Munich at the University Hospital Carl Gustav Carus and Medical Faculty, Dresden, Germany.

K Guan

Institute of Pharmacology and Toxicology, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

C Brunßen

Division of Vascular Endothelium and Microcirculation, Department of Medicine III, Medical Faculty Carl Gustav Carus, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Germany.

G Mueller

Department of Medicine III, Medical Faculty Carl Gustav Carus, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Germany.

V Kamvissi-Lorenz

Division of Diabetes & Nutritional Sciences, Faculty of Life Sciences & Medicine, King’s College London, London, UK.

R Lechler

King’s College London, London, UK.

R Trembath

Department of Medical & Molecular Genetics, King’s College London, London, UK.

M Mayr

School of Cardiovascular Medicine and Science, Faculty of Life Science & Medicine, KCL, London, UK.

L Poston

Department of Women and Children’s Health, School of Life Course Sciences, King’s College London, London, UK.

R Sancho

Department of Medicine III, Medical Faculty Carl Gustav Carus, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Germany.

Centre for Stem Cells and Regenerative Medicine, King’s College London, London, UK.

S Ahmed

Center for Regenerative Therapies Dresden, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

E Alfar

Institute of Pharmacology and Toxicology, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

B Aljani

Center for Regenerative Therapies Dresden, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

T C Alves

Institute for Clinical Chemistry and Laboratory Medicine, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

S Amiel

Department of Diabetes Research, School of Life Course Sciences, Faculty of Life Sciences & Medicine, King’s College London, London, UK.

C L Andoniadou

Department of Medicine III, Medical Faculty Carl Gustav Carus, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Germany.

Craniofacial Development and Stem Cell Biology, KCL, London, UK.

M Bandral

Paul Langerhans Institute Dresden (PLID) of the Helmholtz Center Munich at the University Hospital Carl Gustav Carus and Medical Faculty, Dresden, Germany.

A Belavgeni

Department of Medicine III, Medical Faculty Carl Gustav Carus, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Germany.

I Berger

Department of Medicine III, Medical Faculty Carl Gustav Carus, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Germany.

A Birkenfeld

Department of Medicine III, Medical Faculty Carl Gustav Carus, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Germany.

Division of Diabetes & Nutritional Sciences, Faculty of Life Sciences & Medicine, King’s College London, London, UK.

Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen, Tübingen, Germany.

E Bonifacio

Center for Regenerative Therapies Dresden, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

Paul Langerhans Institute Dresden (PLID) of the Helmholtz Center Munich at the University Hospital Carl Gustav Carus and Medical Faculty, Dresden, Germany.

T Chavakis

Institute for Clinical Chemistry and Laboratory Medicine, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

P Chawla

Paul Langerhans Institute Dresden (PLID) of the Helmholtz Center Munich at the University Hospital Carl Gustav Carus and Medical Faculty, Dresden, Germany.

P Choudhary

Division of Diabetes & Nutritional Sciences, Faculty of Life Sciences & Medicine, King’s College London, London, UK.

A M Cujba

Department of Medicine III, Medical Faculty Carl Gustav Carus, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Germany.

L F Delgadillo Silva

Paul Langerhans Institute Dresden (PLID) of the Helmholtz Center Munich at the University Hospital Carl Gustav Carus and Medical Faculty, Dresden, Germany.

T Demcollari

Centre for Stem Cells and Regenerative Medicine, King’s College London, London, UK.

D M Drotar

Paul Langerhans Institute Dresden (PLID) of the Helmholtz Center Munich at the University Hospital Carl Gustav Carus and Medical Faculty, Dresden, Germany.

S Duin

Department of Medicine III, Medical Faculty Carl Gustav Carus, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Germany.

Centre for Translational Bone, Joint and Soft Tissue Research, Medical Faculty and University Hospital, Technische Universität Dresden, Dresden, Germany.

N N El-Agroudy

Department of Medicine III, Medical Faculty Carl Gustav Carus, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Germany.

A El-Armouche

Institute of Pharmacology and Toxicology, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

A Eugster

Center for Regenerative Therapies Dresden, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

M Gado

Department of Medicine III, Medical Faculty Carl Gustav Carus, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Germany.

A Gavalas

Paul Langerhans Institute Dresden (PLID) of the Helmholtz Center Munich at the University Hospital Carl Gustav Carus and Medical Faculty, Dresden, Germany.

M Gelinsky

Centre for Translational Bone, Joint and Soft Tissue Research, Medical Faculty and University Hospital, Technische Universität Dresden, Dresden, Germany.

M Guirgus

Paul Langerhans Institute Dresden (PLID) of the Helmholtz Center Munich at the University Hospital Carl Gustav Carus and Medical Faculty, Dresden, Germany.

S Hansen

Institute of Pharmacology and Toxicology, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

E Hanton

Peter Gorer Department of Immunobiology, Guy’s Hospital, London, UK.

M Hasse

Institute of Pharmacology and Toxicology, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

H Henneicke

Department of Medicine III, Medical Faculty Carl Gustav Carus, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Germany.

C Heller

Department of Medicine III, Medical Faculty Carl Gustav Carus, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Germany.

H Hempel

C Hogstrand

Department of Nutritional Sciences, Faculty of Life Sciences & Medicine, KCL, London, UK.

D Hopkins

Department of Diabetic Medicine, King’s College Hospital NHS Foundation Trust and KCL, London, UK.

L Jarc

Paul Langerhans Institute Dresden (PLID) of the Helmholtz Center Munich at the University Hospital Carl Gustav Carus and Medical Faculty, Dresden, Germany.

P M Jones

Department of Diabetes Research, School of Life Course Sciences, Faculty of Life Sciences & Medicine, King’s College London, London, UK.

M Kamel

Paul Langerhans Institute Dresden (PLID) of the Helmholtz Center Munich at the University Hospital Carl Gustav Carus and Medical Faculty, Dresden, Germany.

S Kämmerer

Institute of Pharmacology and Toxicology, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

A J F King

Department of Diabetes Research, School of Life Course Sciences, Faculty of Life Sciences & Medicine, King’s College London, London, UK.

A Kurzbach

Department of Medicine III, Medical Faculty Carl Gustav Carus, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Germany.

C Lambert

Centre for Stem Cells and Regenerative Medicine, King’s College London, London, UK.

Y Latunde-Dada

King’s College London, London, UK.

I Lieberam

Centre for Stem Cells and Regenerative Medicine, King’s College London, London, UK.

J Liers

Department of Radiopharmaceutical and Chemical Biology, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany.

J W Li

Center for Regenerative Therapies Dresden, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

A Linkermann

Department of Medicine III, Medical Faculty Carl Gustav Carus, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Germany.

S Locke

Department of Medicine III, Medical Faculty Carl Gustav Carus, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Germany.

B Ludwig

Department of Medicine III, Medical Faculty Carl Gustav Carus, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Germany.

University Hospital Zurich, Department of Endocrinology and Diabetology, Zurich, Switzerland.

Paul Langerhans Institute Dresden (PLID) of the Helmholtz Center Munich at the University Hospital Carl Gustav Carus and Medical Faculty, Dresden, Germany.

Center for Regenerative Therapies Dresden, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

T Manea

Centre for Stem Cells and Regenerative Medicine, King’s College London, London, UK.

F Maremonti

Department of Medicine III, Medical Faculty Carl Gustav Carus, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Germany.

Z Marinicova

Paul Langerhans Institute Dresden (PLID) of the Helmholtz Center Munich at the University Hospital Carl Gustav Carus and Medical Faculty, Dresden, Germany.

B M McGowan

Department of Diabetes and Endocrinology, London, UK.

M Mickunas

Peter Gorer Department of Immunobiology, Guy’s Hospital, London, UK.

G Mingrone

Department of Diabetes Research, School of Life Course Sciences, Faculty of Life Sciences & Medicine, King’s College London, London, UK.

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.

Università Cattolica del Sacro Cuore, Rome, Italy.

K Mohanraj

Institute for Clinical Chemistry and Laboratory Medicine, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

H Morawietz

N Ninov

Paul Langerhans Institute Dresden (PLID) of the Helmholtz Center Munich at the University Hospital Carl Gustav Carus and Medical Faculty, Dresden, Germany.

M Peakman

Peter Gorer Department of Immunobiology, Guy’s Hospital, London, UK.

S J Persaud

Department of Diabetes Research, School of Life Course Sciences, Faculty of Life Sciences & Medicine, King’s College London, London, UK.

J Pietzsch

Department of Radiopharmaceutical and Chemical Biology, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany.

E Cachorro

Institute of Pharmacology and Toxicology, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

T J Pullen

School of Life Course Sciences, Faculty of Life Sciences & Medicine, KCL, London, UK.

I Pyrina

Institute for Clinical Chemistry and Laboratory Medicine, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

F Rubino

Department of Diabetes Research, School of Life Course Sciences, Faculty of Life Sciences & Medicine, King’s College London, London, UK.

A Santambrogio

Department of Medicine III, Medical Faculty Carl Gustav Carus, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Germany.

F Schepp

Department of Medicine III, Medical Faculty Carl Gustav Carus, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Germany.

P Schlinkert

Institute of Pharmacology and Toxicology, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

L D Scriba

Department of Medicine III, Medical Faculty Carl Gustav Carus, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Germany.

R Siow

Vascular Biology & Inflammation Section, School of Cardiovascular Medicine & Sciences, British Heart Foundation of Research Excellence, King’s College London, London, UK.

M Solimena

Paul Langerhans Institute Dresden (PLID) of the Helmholtz Center Munich at the University Hospital Carl Gustav Carus and Medical Faculty, Dresden, Germany.

Molecular Diabetology, University Hospital and Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany.

F M Spagnoli

Centre for Stem Cells and Regenerative Medicine, King’s College London, London, UK.

S Speier

Paul Langerhans Institute Dresden (PLID) of the Helmholtz Center Munich at the University Hospital Carl Gustav Carus and Medical Faculty, Dresden, Germany.

A Stavridou

Center for Regenerative Therapies Dresden, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

C Steenblock

Department of Medicine III, Medical Faculty Carl Gustav Carus, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Germany.

A Strano

Institute of Pharmacology and Toxicology, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

P Taylor

Department of Women and Children’s Health, School of Life Course Sciences, King’s College London, London, UK.

A Tiepner

Institute of Pharmacology and Toxicology, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

W Tonnus

Department of Medicine III, Medical Faculty Carl Gustav Carus, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Germany.

T Tree

Peter Gorer Department of Immunobiology, Guy’s Hospital, London, UK.

F Watt

Centre for Stem Cells and Regenerative Medicine, King’s College London, London, UK.

M Werdermann

Department of Medicine III, Medical Faculty Carl Gustav Carus, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Germany.

M Wilson

School of Life Course Sciences, Faculty of Life Sciences & Medicine, KCL, London, UK.

N Yusuf

Peter Gorer Department of Immunobiology, Guy’s Hospital, London, UK.

C G Ziegler

Department of Medicine III, Medical Faculty Carl Gustav Carus, University Hospital Carl Gustav Carus Dresden, Technische Universität Dresden, Germany.

References

PubMed

Follow Us

The transCampus Metabolic Training Programme Explores the Link of SARS-CoV-2 Virus to Metabolic Disease.

Author

About The Expert

References